{
    "title": "To amend title XVIII of the Social Security Act to provide for coverage of medication therapy management services, including disease specific management services, for certain high-risk patients under the Medicare Program.",
    "content": "SECTION 1. SHORT TITLE; PURPOSE.\n\n    (a) Short Title.--This Act may be cited as the ``Medicare \nMedication Therapy Management Services Coverage Act of 2002''.\n    (b) Purpose.--The purpose of this Act is to provide coverage of \nmedication therapy management services under the medicare program for \nbeneficiaries at risk for potential medication problems, such as \nbeneficiaries taking multiple medications and beneficiaries with \ncomplex or chronic medical conditions.\n\nSEC. 2. MEDICARE COVERAGE OF MEDICATION THERAPY MANAGEMENT SERVICES FOR \n              CERTAIN HIGH-RISK PATIENTS.\n\n    (a) In General.--Section 1861 of the Social Security Act (42 U.S.C. \n1395x) is amended--\n            (1) in subsection (s)(2)--\n                    (A) by striking ``and'' at the end of subparagraph \n                (U);\n                    (B) by adding ``and'' at the end of subparagraph \n                (V); and\n                    (C) by adding at the end the following new \n                subparagraph:\n            ``(W) medication therapy management services (as defined in \n        subsection (ww)(1)(A)) for individuals who are receiving \n        medication for a condition and are otherwise determined to be \n        at high risk (as defined by the Secretary), and including \n        disease specific management services for individuals who are \n        receiving medication for the treatment of asthma or diabetes, \n        lipid reducing medication, anti-coagulation medication, or \n        medication for such other chronic diseases as the Secretary may \n        specify;'';\n            (2) by adding at the end the following new subsection:\n\n     ``Medication Therapy Management Services; Qualified Pharmacist\n\n    ``(ww)(1)(A) The term `medication therapy management services' \nmeans--\n            ``(i) services or programs furnished by a qualified \n        pharmacist in an eligible State which are designed--\n                    ``(I) to assure that medications are used \n                appropriately by individuals;\n                    ``(II) to enhance individuals' understanding of the \n                appropriate use of medications;\n                    ``(III) to increase individuals' compliance with \n                prescription medication regimens;\n                    ``(IV) to reduce the risk of potential adverse \n                events associated with medications; and\n                    ``(V) to reduce the need for other costly medical \n                services through better management of medication \n                therapy; and\n            ``(ii) services provided by qualified pharmacists in \n        collaboration with physicians and other health care \n        professionals when necessary, involving case management, \n        disease management, patient training and education, medication \n        refill reminders, medication therapy problem resolution, \n        laboratory testing conducted to monitor medication therapy, \n        other services of qualified pharmacists that enhance the use of \n        prescription medications, and such other professional services \n        of qualified pharmacists, consistent with the scope of the \n        practice of pharmacy as defined by applicable State law or \n        regulation.\n    ``(B) The term `disease specific management services' means \nmedication therapy management services provided to individuals who are \nreceiving medication for the treatment of asthma or diabetes, lipid \nreducing medication, anti-coagulation medication, or medication for \nsuch other chronic diseases as the Secretary may specify, only pursuant \nto a protocol with the individual's treating physician under which the \nqualified pharmacist may initiate or modify the medication therapy, and \ncarry out such additional medication therapy management services as is \nprovided under State law or regulation, as permitted under the \nprotocol.\n    ``(C) Covered medication therapy management services are covered \nunder this title only if they are documented and shared with the \nappropriate physician and other health care providers (as established \nunder a reporting system developed by State Boards of Pharmacy).\n    ``(2) The term `qualified pharmacist' means an individual who--\n            ``(A) is a licensed pharmacist in good standing with the \n        State Board of Pharmacy;\n            ``(B) with respect only to the provision of disease \n        specific management services, is currently certified by a \n        nationally recognized licensed certification or credentialing \n        program to furnish medication management therapy services for \n        the diseases referred to in paragraph (1)(B); and\n            ``(C) has a separate, private consultation area in which to \n        provide covered.\n    ``(3) The term `eligible State' means a State that meets such \ncriteria as the Secretary may establish for the licensing or \ncredentialing of qualified pharmacists for the provision of medication \ntherapy management services in the State, and shall include a State \nthat is eligible for payments under title XIX for the provision of such \nservices under the State plan.''; and\n            (3) in subsection (aa)(6), by inserting ``(or, with respect \n        to subsection (ww)(1)(B), a qualified pharmacist)'' after \n        ``nurse practitioner'' and by inserting ``(or pharmacist's)'' \n        after ``practitioner's''.\n    (b) Payment.--\n            (1) In general.--Section 1833(a)(1) of such Act (42 U.S.C. \n        1395l(a)(1)) is amended--\n                    (A) in subsection (a)(1)--\n                            (i) by striking ``and'' before ``(U)''; and\n                            (ii) by inserting before the semicolon at \n                        the end the following: ``, and (V) with respect \n                        to covered medication therapy management \n                        services (as defined in section 1861(ww)(1)), \n                        the amounts paid shall be 80 percent of the \n                        lesser of the actual charge or the amounts \n                        specified under the fee schedule developed \n                        under subsection (p)''; and\n                    (B) by inserting after subsection (o) the following \n                new subsection:\n    ``(p) With respect to medication therapy management services (as \ndefined in section 1861(ww)(1)), the Secretary shall establish a fee \nschedule--\n            ``(1) under which payments are based on an encounter and \n        increase in 15 minute increments; and\n            ``(2) in which, in order to be paid for a 15-minute \n        increment, the majority of the time be spent by the qualified \n        pharmacist in providing covered services.''.\n            (2) Application of balance billing limitations.--Section \n        1842(b)(18)(C) of such Act (42 U.S.C. 1395u(b)(18)(C)) is \n        amended by adding at the end the following new clause:\n            ``(vii) A qualified pharmacist (as defined in section \n        1861(ww)(2)).''.\n            (3) Report to congress.--Not later than 3 years after the \n        date of the enactment of this Act, the Secretary of Health and \n        Human Services shall submit to Congress a report on fee \n        schedule developed under section 1834(p) of the Social Security \n        Act (as added by paragraph (1)) for covered medication therapy \n        management services under part B of the medicare program.\n    (c) Program Operation.--\n            (1) Development in consultation with pharmacy \n        organizations.--The Secretary of Health and Human Services \n        shall carry out the amendments made by this section in \n        cooperation with organizations representing qualified \n        pharmacists, including--\n                    (A) identifying medication therapy management \n                services that will be covered; and\n                    (B) establishing payment mechanisms for such \n                services.\n            (2) Ongoing evaluation.--The Secretary shall provide for an \n        ongoing evaluation and documentation of the provision of \n        medication therapy management services under such amendment in \n        improving quality of care and reducing health care costs.\n    (d) Effective Date.--The amendments made by this section shall \napply to services furnished on or after January 1, 2004."
}